 ANAHEIM, CA, March 02, 2021 GLOBE NEWSWIRE -- via NewMediaWire -- BioCorRx Inc. OTCQB: BICX the Company, a developer and provider of advanced solutions in the treatment of substance use disorders, today announced that the Company completed a private placement, whereby it issued 1.125 million common stock shares at a price of 2.00 per share, for total proceeds of 2.25 million. The private placement was done with Louis Lucido and Joseph Galligan, both members of the Companys Board of Directors. 